Advanced Plant Pharmaceuticals Inc. - APPI - Signs
Exclusive Distribution Agreement with Ambar Pharmacies
and Health
PR Newswire - June 30, 1999 10:45
NEW YORK, June 30 /PRNewswire/ -- Advanced Plant Pharmaceuticals, Inc. (OTC Bulletin
Board: APPI) a company that utilizes whole plants to develop all natural dietary supplements, signed
an exclusive Distribution Agreement with Ambar Pharmacies and Health, Inc. in which Ambar agrees
to distribute stated minimums of APPI's products in Israel.
The exclusive agreement, APPI's first firm commitment from an overseas corporation, requires
Ambar to purchase certain minimum quantities of APPI's dietary supplements, "ACA" and
"Lo-Chol."
Ambar, which was established by Ambar Abraham a licensed pharmacist, and Dr. Reuven Barak
M.D., distributes Chinese medicines and all natural products to pharmacies, hospitals, clinics, shops,
and practitioners all over Israel. Ambar has the largest updated mailing list of practitioners with
patients, most of which are working with Ambar.
"Your company holds a product, that the Israeli market requires," said Ambar Abraham, General
Manager for Ambar. "With our expertise, we will take responsibility for the marketing of your
products." Mr. Abraham further stated, "the advantage of us representing APPI is that we will
exclusively focus on your products, in terms of bringing the sales to their maximum money potential."
APPI, which is currently negotiating similar overseas distribution agreements, hopes that this
agreement with Ambar will be the first of many distribution agreements. APPI, after several years of
research and development, began marketing its products in January of this year.
The company hopes to announce further agreements in the near future.
Company information, and ordering of product can be obtained on APPI's Internet web site located
at advancedplantpharm.com
APPI is a company that develops innovative plant formulations and technology for clinical application.
APPI has met FDA nutritional specifications for the marketing of its Cholesterol lowering agent
"Lo-Chol" in the USA, and has received the first IND from the FDA for a whole plant
pharmaceutical, Abavca/ACA, which has potential as an immunomodulater in the treatment of
patients infected with HIV, the virus that causes AIDS.
APPI's Whole Plant Pharmaceutical Grade Process is trade secret and patent pending. Utilization of
the APPI process converts a whole plant into the best standardized pharmaceutical grade product.
This press release contains forward-looking statements. Such statements are subject to certain risks
and uncertainties and actual results could differ materially from those expressed in any of the
forward-looking statements.
CONTACT: Barry Clare of Advanced Plant Pharmaceuticals Inc., 212-402-7878; or Ambar
Abraham of Ambar Pharmacies & Health, +972-3-75235543.
|
